|
2026
|
P/S
|
Pharmaceutical preparations for use in the treatment of cancer, oncology, tumors, solid and hemat... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of diabetes,
endocrine diseases and disorders, met... |
|
|
P/S
|
Providing online non-downloadable informational content in the field of musculoskeletal health an... |
|
|
P/S
|
Pharmaceutical preparations for treating alopecia, Alzheimer's disease, atopic dermatitis, autoim... |
|
|
P/S
|
Pharmaceutical preparations for treating alopecia,
Alzheimer's disease, atopic dermatitis, autoi... |
|
|
P/S
|
Pharmacy services; online retail pharmacy services; mail order pharmacy services; online retail s... |
|
|
P/S
|
pharmaceutical preparations; pharmaceutical preparations for the treatment of cancer; pharmaceuti... |
|
|
P/S
|
pharmaceutical preparations;pharmaceutical preparations for the treatment of cancer;pharmaceutica... |
|
|
P/S
|
educational services, namely development and dissemination of educational materials in the field ... |
|
|
P/S
|
Pharmaceutical preparations for treating cancer and oncological disorders; Pharmaceutical prepara... |
|
|
P/S
|
Injectors for medical purposes pre-filled with pharmaceutical preparations for treating cancer, i... |
|
2025
|
Invention
|
Systems and methods for assessing cell growth rates.
A method of facilitating a growth assessmen... |
|
|
Invention
|
Mesothelin-targeted cd40 agonistic multispecific antibody constructs for the treatment of solid t... |
|
|
Invention
|
Control of total afucosylated glycoforms of antibodies produced in cell culture.
Provided herein... |
|
|
P/S
|
Injectors for medical purposes pre-filled with pharmaceutical preparations for treating oncology,... |
|
|
P/S
|
Injectors for medical purposes pre-filled with
pharmaceutical preparations for treating oncology... |
|
|
Invention
|
Titration doses of maridebart cafraglutide. The present invention relates to methods of treating ... |
|
|
Invention
|
Drive assembly for a drug delivery device and related methods. Drive assemblies for a drug delive... |
|
|
Invention
|
Drive assembly for a drug delivery device and related methods.
Drive assemblies for a drug deliv... |
|
|
Invention
|
Methods of treating obesity and obesity-related conditions. The present invention relates to meth... |
|
|
Invention
|
Systems and methods for inspecting drug containers. Systems and methods for inspecting one or mor... |
|
|
Invention
|
Combination therapy of a prmt5 inhibitor and daraxonrasib for use in the treatment of mtap-null c... |
|
|
Invention
|
5,6-fused bicyclic alcohol compounds as 15-prostaglandin dehydrogenase modulators. Disclosed here... |
|
|
Invention
|
5,6-fused bicyclic alcohol compounds as 15-prostaglandin dehydrogenase modulators.
Disclosed her... |
|
|
Invention
|
Drug delivery device and related methods. A drug delivery device (10, 100, 200) which includes a ... |
|
|
Invention
|
Proteins specific for baff and b7rp1 and uses thereof.
Described herein are bispecific proteins ... |
|
|
Invention
|
Synthetic processes for pharmaceutically active compounds. 2 2 to afford a compound of Compound 1. |
|
|
Invention
|
Loci with increased transgene expression and uses thereof. The present disclosure relates to meth... |
|
|
Invention
|
Drug delivery device and related methods. A drug delivery device may include a housing having a d... |
|
|
Invention
|
Methods of determining glycan pairing content. Methods of determining glycan pairing content of a... |
|
|
Invention
|
Process for manipulating the level of glycan content of a glycoprotein.
The present invention pr... |
|
|
Invention
|
Kif18a inhibitors.
Compounds of formula (I):
Compounds of formula (I):
Compounds of form... |
|
|
Invention
|
Systems, devices, and methods for measuring components. Systems for measuring a drug container cl... |
|
|
Invention
|
Dosing regimen for anti-dll3 agent. The disclosure relates to compositions and methods for treati... |
|
|
Invention
|
Flt1 binding proteins and methods of use. Provided herein are FLT1 binding proteins, as well as r... |
|
|
Invention
|
Single-chain fab proteins and uses thereof. The present invention relates to the field of protein... |
|
|
Invention
|
Subcutaneous administration of anti-dll3 agent for treatment of cancer. Provided herein is a meth... |
|
|
Invention
|
Methods of detecting off-target binding of proteins.
The present invention relates to methods of... |
|
|
Invention
|
Macrocyclic compounds as modulators of kras and uses thereof. Disclosed herein are compounds usef... |
|
|
Invention
|
Production of viral stocks. Methods of producing Minute Mouse Virus (MMV) stock are described her... |
|
|
Invention
|
Disruption of vascular smooth muscle relaxation by carfilzomib may be the primary reason for cfz-... |
|
|
Invention
|
Use of oncolytic viruses, alone or in combination with a checkpoint inhibitor, for the treatment ... |
|
|
Invention
|
Sequential digestion of polypeptides for mass spectrometric analysis.
The disclosed methods are ... |
|
|
Invention
|
Piperidinone derivatives as mdm2 inhibitors for the treatment of cancer.
The present invention p... |
|
|
Invention
|
Handheld drug delivery device |
|
2024
|
Invention
|
Damper overfill chamber to increase functional robustness regarding variance in parts and process... |
|
2023
|
Invention
|
Cancer treatments using mta-cooperative prmt5 inhibitors and mat2a inhibitors.
Described herein ... |
|
|
Invention
|
Heterocyclic inhibitors of kras g12c mutant proteins and uses thereof.
The present disclosure pr... |
|
|
Invention
|
Combination therapies comprising t-cell redirecting therapies and agonistic anti-il-2r antibodies... |
|
|
Invention
|
A method for harvesting products from high cell density perfusion cell cultures.
The disclosure ... |
|
|
Invention
|
Bispecific molecule stabilizing composition.
The present invention provides provide a pharmaceut... |
|
|
Invention
|
Predictive model to evaluate processing time impacts.
Systems and methods for evaluating impacts... |
|
|
Invention
|
Methods of treating cancer.
Provided herein are methods of treating a cancer in a patient wherei... |
|
|
Invention
|
Methods for treating cancer.
Provided herein are methods of treating cancer comprising a KRAS G1... |
|
|
Invention
|
Magea4 specific t cell receptors.
Provided herein are recombinant T-cell receptors (TCRs) that c... |
|
|
Invention
|
Clearance of aggregates from uf/df pools in downstream antibody purification.
A method for impro... |
|
2022
|
Invention
|
Sotorasib dosing regimen.
The present disclosure provides method of administering sotorasib to a... |
|
|
Invention
|
Drug delivery devices, components for use within drug delivery devices, and methods of operating ... |
|
2021
|
Invention
|
Polypeptide constructs selectively binding to cldn6 and cd3.
The present invention relates to a ... |
|
2012
|
Invention
|
Methods and apparati for nondestructive detection of undissolved particles in a fluid |
|
|
Invention
|
Autoinjector apparatus |
